• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Tumor Necrosis Factor-Receptor Associated Periodic Syndrome (TRAPS) - Articles and news items

Expanded use for Novartis’ Periodic Fever Syndrome drug after 3 new FDA approvals

Industry news / 27 September 2016 / Niamh Louise Marriott, Digital Content Producer

The expanded use is for Ilaris, a selective, high-affinity, human monoclonal antibody that inhibits Interleukin-1 (IL-1) beta, part of the immune system…


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +